Fertility Center—Westchester Doctors | NYU Langone Health
Find a doctor at the Fertility Center—Westchester at NYU Langone.
Fertility Options for LGBTQ+ Families at NYU Langone Reproductive Specialists of New York | NYU Langone Health
At NYU Langone Reproductive Specialists of New York, we provide fertility services for the LGBTQ+ community.
Fertility Preservation for People with Cancer | NYU Langone Health
Doctors at the NYU Langone Fertility Center are experts in preserving the fertility of individuals dealing with cancer.
Fertility Services | NYU Langone Health
At NYU Langone, our reproductive endocrinologists are leaders in fertility testing, treatment, and preservation for individuals and couples.
Fertility Services for the LGBTQ+ Community | NYU Langone Health
The NYU Langone Fertility Center is proud to offer a variety of fertility services, including IVF and surrogacy, to the LGBTQ+ community.
Fertility-Sparing Options for Cervical Cancer | NYU Langone Health
Whenever possible, NYU Langone doctors aim to preserve fertility in women with cervical cancer.
Fertility-Sparing Procedures for Ovarian Cancer | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center perform procedures that can help preserve fertility in women who have ovarian cancer.
Fertility Testing at NYU Langone Reproductive Specialists of New York | NYU Langone Health
Doctors at NYU Langone Reproductive Specialists of New York use fertility testing to determine the cause of infertility.
Fertility Wellness Program | NYU Langone Health
NYU Langone’s Fertility Center has many classes and services available to help you manage stress and prepare your body for pregnancy.
Ferumoxytol-enhanced MRI of Cerebrovascular Diseases
The purpose of this research study is to assess new magnetic resonance imaging methods and a new contrast agent for the evaluation of cerebrovascular diseases. It is hoped that these techniques will enable researchers and clinicians to better detect cerebrovascular diseases. The images collected of the brains of patients with cerebrovascular diseases will be compared to the images from healthy volunteers to assess the technique and agent's sensitivity.